Health Watch USA Logo Kentucky Legislative Testimony on Public Reporting of Healthcare Associated Infections - Transparency of Healthcare Acquired Conditions

Never Events
 
Healthcare in the USA
 
Health Care Value
 
Transparency Costs
 
Transparency Quality
 
Health Care Competition
 
Freedom of Information

 Subscribe Newsletter
 Report an Incident Misson & Positions
 
To Contact
Health Watch USAsm

please use the following
E-Mail Address:

   
 

Health Policy to Patient 
Health Watch USAsm 
Serves to Promote Healthcare Value, Transparency and Quality
    
A member of the National Quality Forum and
a designated "Community Leader" for Value-Driven Healthcare  by the U.S. Dept. of Health and Human Services.

Famous Quotes

Thomas R. Frieden, Director of the CDC, has stated “Evidence indicates that, with focused efforts, these once formidable infections can be greatly reduced in number, leading to a new normal for healthcare-associated infections as rare, unacceptable events”. -- October 2011 http://www.journals.uchicago.edu/doi/full/10.1086/656002  
   

Legislative Testimony Videos
2013 Healthcare Conference
Facility Fees & Medicare Financing

  • A perspective on how the United States Fell behind Northern Europe in the battle against methicillin-resistant Staphylococcus aureus.Given the evidence, it is unclear why the U.S. health care industry has not embraced ADI (active detection and isolation) as an integral part of infection control. Some patient advocates believe that one of the reasons is to prevent the passage of legislative mandates. If this is the case, the best way to prevent legislative mandates is by having a quality health care system that adopts and implements standards of care based upon the best evidence available. In view of the severity of the MDRO epidemic in the United States, a reevaluation of the setting of standards of care for the expanded and uniform use of active MRSA surveillance testing should be undertaken. --- Kavanagh KT, Saman DM, Yu Y. A perspective on how the united states fell behind Northern Europe in the battle against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2013 Dec;57(12):5789-91. doi: 10.1128/AAC.01839-13. Epub 2013 Oct 7.
  • Moving Heatlhcare Quality Forward With Nursing Sensitive Value-Based PurchasingValue-based purchasing is in its infancy. Devising an effective system that recognizes and incorporates nursing measures will facilitate the success of this initiative. NSVBP needs to be designed and incentivized to decrease adverse events, hospital stays, and readmission rates, thereby decreasing societal healthcare costs. At the heart of NSVBP is the concept that one cannot have a quality institution without providing highly trained and skilled nursing care. Yet nursing is at risk for inadequate support, both in staffing numbers and skill mix, particularly in today’s cost-driven and financially stressed healthcare delivery systems. --- Kavanagh KT, Cimiotti JP, Abusalem S, Coty MB. Moving healthcare quality forward with nursing-sensitive value-based purchasing. J Nurs Scholarsh. 2012 Dec;44(4):385-95. doi: 10.1111/j.1547-5069.2012.01469.x. Epub 2012 Oct 15.
  • The Relationship Between Tort Reform and Medical UtilizationThe comparison of the Dartmouth Atlas Medicare Reimbursement Data with Malpractice Reform State Rankings, which are used by the PRI, did not support the hypothesis that defensive medicine is a driver of rising health-care costs. Additionally, comparing Medicare reimbursements, premedical and postmedical tort reform, we found no consistent effect on health-care expenditures. Together, these data indicate that medical tort reform seems to have little to no effect on overall Medicare cost savings. --- Kavanagh KT, Calderon LE, Saman DM. The Relationship Between Tort Reform and Medical Utilization. J Patient Saf. 2013 Oct 7. [Epub ahead of print]
  • Can Inpatient Hospital Experiences Predict Central Line-Assoicated Bloodstream InfectionsUsing national datasets, we found that inpatients' hospital experiences were significantly associated with an increased risk of ICU reported CLABSIs. This study suggests that hospitals with lower staff responsiveness, perhaps because of an understaffing of nurse and supportive personnel, are at an increased risk for CLABSIs. This study bolsters the evidence that patient surveys may be a useful surrogate to predicting the incidence of hospital acquired conditions, including CLABSIs. Moreover, our study found that poor staff responsiveness may be indicative of greater hospital problems and generally poorly performing hospitals; and that this finding may be a symptom of hospitals with a multitude of problems, including patient safety problems, and not a direct cause. --- Saman DM, Kavanagh KT, Johnson B, Lutfiyya MN. Can inpatient hospital experiences predict central line-associated bloodstream infections? PLoS One. 2013;8(4):e61097. doi: 10.1371/journal.pone.0061097. Epub 2013 Apr 5.
  • A tale of two cows: Why we have a cow map and not a healthcare acquired infection mapIf there is a USA Beef Cow Density Map by county, why can't we have a MRSA map or a map for all Health Care Acquired Infections ?? Posted by the Center for Disease Dynamics, Economics and Policy. Authors: Dr Daniel Saman, DrPH, MPH, CPH and Dr Kevin Kavanagh, MD, MS, FACS
  • Redefining the Standarized Infection Ratio to Aid in Consumer Value PurchasingTo be most understandable to the consumer, the Standarized Infection Ratio National Benchmark of 1.0 should reflect what is obtainable. The SIR is a tool intended to be used by consumers in value purchasing to compare differences between facilities and thus should not adjust for these differences. Ideally, factors used in risk adjustment should solely be based upon patient characteristics. Thus, facility-specific adjustments (i.e., medical school affiliation, major teaching institution and unit bed size) should be used with caution in calculating the SIR and their use made clearly transparent to health-care consumers --- Saman DM, Kavanagh KT, Abusalem SK. Redefining the standardized infection ratio to aid in consumer value purchasing. J Patient Saf. 2013 Jun;9(2):55-8. doi: 10.1097/PTS.0b013e3182809f31.
  • Assessing the Necessity of the Standarized Infection Ratio for Reporting Central Line-Associated Bloodstream InfectionsEvidence is mounting that all hospitals should be able to achieve a near zero incidence of CLABSIs and that these infections may in fact be near 'never events', which begs whether risk adjustment with the SIR is needed and whether it adds more information than does rate adjustment using CLABSI rates. … nearly 70% of 1721 reporting hospitals with at least 1000 central line days had five or fewer infections during 2011. These hospitals had 39.3% of the total central line days and a significantly lower SIR than poorer performing hospitals with six or more CLABSIs (p<0.0001). In addition, 19 hospitals are presented which had central line days between 9000 to over 22,000 that also had zero to three CLABSIs. --- Saman DM, Kavanagh KT. Assessing the necessity of the standardized infection ratio for reporting central line-associated bloodstream infections. PLoS One. 2013 Nov 4;8(11):e79554. doi: 10.1371/journal.pone.0079554. eCollection 2013.
  • A Perspective on the Evidence Regarding Methicillin-resistant Staphylococcus aureus SurveillanceTwo prominent studies have been used by policy makers to prevent the enactment of standards of care regarding active surveillance of patients with methicillin-resistant Staphylococcus aureus in hospital settings. In this brief review and perspective of those studies, we contend that both studies have serious limitations (i.e., the intervention group was not given optimal intervention) that may not have been scrutinized by many policy makers, health officials, and other researchers. These studies seem to have had a disproportionate impact on health-care policy despite their limitations. Furthermore, health-care policy and treatment standards need to reflect the preponderance of evidence with appropriate weight given to research studies based on their strengths and limitations. --- Kavanagh K, Abusalem S, Saman DM. A perspective on the evidence regarding methicillin-resistant Staphylococcus aureus surveillance. J Patient Saf. 2012 Sep;8(3):140-3. doi: 10.1097/PTS.0b013e3182627b89.
  • Financial Incentives to Promote Health Care Quality”  The Hosptial Acquired ConditionNonpayment PolicAs a further initiative to promote quality, financial incentives have been implemented by the Centers for Medicare and Medicaid Services. Surgeons have lived under stringent financial incentives since the mid-1980s when they were placed under global surgical fees. Medicare currently must make expenditure reductions because it is at risk of becoming insolvent within the decade. Implementation of financial incentives should depend upon a balance between the nonpayment of providers for nonpreventable HAC verses the promotion of health care quality and patient safety, the reduction in patient morbidity and mortality, the spurring of mechanisms to further reduce HAC, and the recouping of taxpayer dollars for HAC that could have been prevented. --- Kavanagh KT. Financial incentives to promote health care quality: the hospital acquired conditions nonpayment policy. Soc Work Public Health. 2011;26(5):524-41. doi: 10.1080/19371918.2011.533554.
1 2 3 4 5 6 7 8 9

  Health Watch USA Facebook PageVisit and Like Our Facebook Page
    
Go To Facebook Page
Health Watch USA - Newsletter Subscribe to Health Watch USAsm
Newsletter  Go To Subscription Page